Efficacy and Safety of Transcutaneous Electrical Acupoint Stimulation for Primary Dysmenorrhoea
Overview
Primary dysmenorrhoea (PD) causes significant physical and psychosocial impacts. This study aims to assess the effectiveness and safety of transcutaneous electrical acupoint stimulation (TEAS) in managing PD symptoms.
Study Design
60 participants with moderate to severe PD will be recruited and randomly assigned to a TEAS group or a TEAS-sham group. The TEAS group will undergo 12 sessions of TEAS treatment over two menstrual cycles, while the TEAS-sham group will receive simulated TEAS treatment without current output.
Outcomes
The primary outcome is pain assessment using the Visual Analogue Scale (VAS). Secondary outcomes include measures of pain, uterine artery haemodynamics, hormone levels, mental well-being, and quality of life. Adverse events and use of analgesics will also be recorded.
Ethics and Dissemination
The study has been approved by the Medical Ethics Committee and results will be submitted for publication in a peer-reviewed journal.
Clinical Trial Support
Clinical trials play a crucial role in developing safe and effective treatments. Our AI-driven platform, DocSym, consolidates clinical protocols and research into a single, easily accessible knowledge base for clinicians.
Streamlining Healthcare Operations
Our mobile apps support scheduling, monitoring treatments, and telemedicine, making it easier to manage patient care and expand services digitally, ultimately improving patient outcomes and reducing paperwork.
AI for Clinics
By utilizing AI, clinics can enhance their workflows and improve patient outcomes. Learn more about how we can help at aidevmd.com.
